Wendy Atkin (17 February 1950 – 27 July 2018) was a British epidemiologist who specialised in the study and implementation of colorectal cancer screening. She held the position of Professor of Epidemiology at University College London (UCL) and served as Director of the UCL Cancer Epidemiology Unit. Atkin’s research contributed substantially to the development of national bowel‑cancer screening programmes in the United Kingdom and informed international screening guidelines.
Early life and education
Atkin was born in London, England. She earned a Bachelor of Science degree in physiology, followed by a PhD in epidemiology from the University of London. Her doctoral work focused on population‑based studies of cancer incidence.
Academic and research career
After completing her doctorate, Atkin worked at the Department of Epidemiology and Public Health at the University of Nottingham, where she began investigations into the utility of faecal occult blood testing (FOBT) for early detection of colorectal cancer. In the early 1990s she led the Nottingham Randomised Controlled Trial of FOBT, which demonstrated a statistically significant reduction in colorectal cancer mortality among screened participants. The findings provided key evidence for the feasibility and efficacy of population‑based FOBT screening.
In 1999 Atkin joined University College London, where she established the Cancer Epidemiology Unit. Under her leadership, the unit conducted large‑scale prospective cohort studies and randomized trials evaluating screening technologies, risk factors, and health‑service outcomes. Her work directly supported the design and rollout of the NHS Bowel Cancer Screening Programme, launched in England in 2006.
Publications and impact
Atkin authored or co‑authored more than 300 peer‑reviewed articles, reviews, and book chapters. Her publications were cited extensively in the fields of cancer epidemiology and public health policy. According to citation metrics, her work has an h‑index exceeding 80, reflecting a substantial influence on subsequent research and clinical practice.
Professional affiliations and honours
- Fellow of the Academy of Medical Sciences (FMedSci)
- Fellow of the European Society of Epidemiology
- President of the International Society for Cancer Epidemiology (ISCE) (2010‑2012)
- Officer of the Order of the British Empire (OBE) for services to cancer research, appointed in the 2016 New Year Honours
Legacy
Wendy Atkin is regarded as a leading figure in the field of cancer prevention, particularly for her contributions to evidence‑based colorectal cancer screening. Her research helped shape public‑health strategies that aim to reduce cancer mortality through early detection. At the time of her death in 2018, she continued to advise governmental and international bodies on cancer‑screening policies.